The Cost-Effectiveness of Treatment Strategies for Obesity - Frankly Speaking Ep 385

Release Date:

Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-385
Overview: Through the framework of a case-based scenario, this episode explores both pharmacological and surgical treatment options for obesity. We discuss the efficacy and cost challenges of injectable medications, insurance coverage, and alternative payment solutions. Gain valuable insights into the cost-effectiveness of treatments, including recent research on endoscopic sleeve gastroplasty, to better advise patients.
Episode resource links:
Haseeb M, Chhatwal J, Xiao J, Jirapinyo P, Thompson CC. Semaglutide vs Endoscopic Sleeve Gastroplasty for Weight Loss. JAMA Netw Open. 2024;7(4):e246221. doi:10.1001/jamanetworkopen.2024.6221
https://obesitymedicine.org/blog/does-insurance-cover-weight-loss-medication/

Guest: Jillian Joseph, PA-C
 
Music Credit: Richard Onorato

The Cost-Effectiveness of Treatment Strategies for Obesity - Frankly Speaking Ep 385

Title
Tirzepatide: A New Treatment for Diabetes - Frankly Speaking Ep 285
Copyright
Release Date

flashback